Medtronic/MDT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Medtronic

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Ticker

MDT

Sector

Healthcare

Trading on

NYSE

Industry

Health Care Equipment and Supplies

Headquarters

Dublin, Ireland

Employees

95,000
Website
www.medtronic.com

Medtronic Metrics

BasicAdvanced
$99B
Market cap
27.94
P/E ratio
$2.76
EPS
0.84
Beta
$2.76
Dividend rate
3.58%
Dividend yield
$99B
0.84
$2.76
2.033
1.31
49.131
49.631
99.73%
8.98%
4.43%
7.26%
27.94
3.16
2.01
-25.31
19.69
3.58%
3.64%
-2.13%
2.43%
1.24%
5.96%

What the Analysts think about Medtronic

Analyst Ratings

Majority rating from 34 analysts.
Buy

Medtronic Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.61% profit margin
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$8.6B
6.18%
Net income
$654M
-50.53%
Profit margin
7.61%
-53.43%

Medtronic Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 0.69%
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
$1.20
$1.25
$1.30
$1.46
-
Expected
$1.11
$1.18
$1.26
$1.45
$1.20
Surprise
8.24%
5.86%
3.13%
0.69%
-

Medtronic News

AllArticlesVideos

Medtronic to announce financial results for its fourth quarter and full fiscal year 2024

PRNewsWire·2 months ago

Arecor shares higher after Medtronic deal; broker remains upbeat

Proactive Investors·2 months ago

Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery

GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

Jul
12
Medtronic
Dividend·Payment
$0.70
Per share

FAQs

What’s the current market cap for Medtronic stock?

Medtronic (MDT) has a market cap of $99B as of July 03, 2024.

What is the P/E ratio for Medtronic stock?

The price to earnings (P/E) ratio for Medtronic (MDT) stock is 27.94 as of July 03, 2024.

Does Medtronic stock pay dividends?

Yes, the Medtronic (MDT) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $2.76 and the yield is 3.58%. Medtronic has a payout ratio of 99.73% on a trailing twelve-month basis.

When is the next Medtronic dividend payment date?

The next Medtronic (MDT) dividend payment is scheduled for July 12, 2024.

What is the beta indicator for Medtronic?

Medtronic (MDT) has a beta rating of 0.84. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Medtronic stock

Buy or sell Medtronic stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing